Observing patients with severe allergic reactions
Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
This study looks at patients who have had severe allergic reactions to better understand what causes them and how to manage them in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Berlin) |
| Trial ID | NCT05210543 on ClinicalTrials.gov |
What this trial studies
The Anaphylaxis Registry collects standardized data on symptoms, triggers, cofactors, and therapy management from patients who have experienced anaphylaxis. This observational study aims to enhance the understanding of anaphylactic reactions, which could lead to improved diagnosis and long-term management strategies. Optional blood sampling may provide insights into sensitization profiles and potential biomarkers associated with these reactions. By identifying triggers and understanding the pathology, the study seeks to reduce the risk of future anaphylactic episodes.
Who should consider this trial
Good fit: Ideal candidates are individuals who have experienced an anaphylactic reaction within the past 12 months.
Not a fit: Patients who have not had an anaphylactic reaction in the past year will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better diagnosis and prevention strategies for patients at risk of anaphylaxis.
How similar studies have performed: Other studies have shown success in identifying biomarkers related to anaphylaxis, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Anaphylactic reaction within the past 12 months Exclusion Criteria: \-
Where this trial is running
Berlin
- Charité - Universitätsmedizin Berlin — Berlin, Germany (Recruiting)
Study contacts
- Study coordinator: Margitta Worm, Prof.
- Email: margitta.worm@charite.de
- Phone: +49 30 450 518105
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.